Should you buy Outlook Therapeutics (OTLK) in 2020?
Outlook Therapeutics (OTLK) is a clinical stage bio-pharmaceutical working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications. Outlook Therapeutics’